Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of puerarin in preparing medicine for treating myopia

A technology of puerarin and medicine, applied in the application field of puerarin medicinal properties, can solve problems such as regulating paralysis

Inactive Publication Date: 2006-03-01
程娟
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to solve the technical difficulties that existing drugs for the treatment of myopia have side effects such as mydriasis and regulation of paralysis, and provide a use of puerarin with very little side effect for the manufacture of drugs for the treatment of myopia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0016] The method of the present invention is the application of puerarin as a medicine for treating myopia. Its medicine is the eye drop aqueous solution containing 1% puerarin. The specific method of use is as follows: 1% puerarin eye drops are used for the prevention and treatment of myopia eye disease in teenagers, and the eye drops are applied locally, twice a day.

[0017] 120 cases of myopia patients were randomly selected, aged 9 to 13 years, diopter between -1.00D---6.00D, half male and half male, randomly divided into 3 groups according to the order of visit time, 40 cases in each group; Eye examination excludes other eye diseases. 1. Visual acuity is checked and recorded with a logarithmic vision chart. 2. Retinoscopy after mydriasis. 3. Measure the axial length and intraocular pressure. The first group was the blank control group, without any treatment; the second group was treated with 1% puerarin eye drops locally, twice a day; the third group was treated with...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the use of puerarin in preparing medicine for treating myopia, and belongs to the field of the medicinal application of puerarin. The medicine of puerarin for treating myopia has the advantages of high curative effect and less side effect.

Description

technical field [0001] The invention relates to the use of puerarin in the manufacture of medicines for treating myopia, which belongs to the application of puerarin medicine properties. Background technique [0002] Myopia is a medical disease that is extremely difficult to treat. In the past 20 years, countries have shown great interest in the treatment of myopia. With the development of high technology and in-depth research on the etiology of myopia and animal experiments, the treatment of myopia It has also entered a new stage, except that a variety of surgical treatments have occurred, and non-surgical treatment of myopia has received widespread attention. In recent years, the only effective drug treatment in the world in recent years is atropine, which can prevent or slow down the development of myopia. Contents of the invention [0003] The purpose of the present invention is to solve the technical difficulties that existing drugs for the treatment of myopia have s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7048A61P27/10
Inventor 程娟王润生
Owner 程娟
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com